| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.03 |